Papers

2

Total Citations

6

H-Index

2

About

Dr. R. Vives-Dilmes is a distinguished urologic surgeon whose research centers on advancing robotic-assisted surgical techniques for prostate cancer, with a particular focus on optimizing oncologic outcomes. His landmark study, "Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomy" (2020), established a robust evidence base for the safety and efficacy of robotic surgery in a large, real-world patient population. This work, cited over 4 times, provides critical benchmarks for surgical margins, biochemical recurrence, and long-term cancer control, directly informing clinical practice. Dr. Vives-Dilmes further disseminated these findings in Spanish ("Resultados oncológicos de un programa de prostatectomía radical asistida por robot «da Vinci»"), ensuring accessibility for the global urology community. His contributions are particularly notable for demonstrating that high-volume robotic programs can achieve excellent oncologic results, helping to standardize best practices. By systematically documenting outcomes from a consecutive cohort, Dr. Vives-Dilmes has provided invaluable data for surgeons adopting or refining robotic prostatectomy, ultimately improving patient care and surgical decision-making.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomy
4 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Hospital Clínico San Carlos, Universidad Complutense de Madrid

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago